407 related articles for article (PubMed ID: 17205078)
1. Bcl-2 family proteins are essential for platelet survival.
Zhang H; Nimmer PM; Tahir SK; Chen J; Fryer RM; Hahn KR; Iciek LA; Morgan SJ; Nasarre MC; Nelson R; Preusser LC; Reinhart GA; Smith ML; Rosenberg SH; Elmore SW; Tse C
Cell Death Differ; 2007 May; 14(5):943-51. PubMed ID: 17205078
[TBL] [Abstract][Full Text] [Related]
2. A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma.
Chauhan D; Velankar M; Brahmandam M; Hideshima T; Podar K; Richardson P; Schlossman R; Ghobrial I; Raje N; Munshi N; Anderson KC
Oncogene; 2007 Apr; 26(16):2374-80. PubMed ID: 17016430
[TBL] [Abstract][Full Text] [Related]
3. BH3-mimetic ABT-737 induces strong mitochondrial membrane depolarization in platelets but only weakly stimulates apoptotic morphological changes, platelet shrinkage and microparticle formation.
Gyulkhandanyan AV; Mutlu A; Allen DJ; Freedman J; Leytin V
Thromb Res; 2014 Jan; 133(1):73-9. PubMed ID: 24268298
[TBL] [Abstract][Full Text] [Related]
4. The BH3-mimetic ABT-737 induces mast cell apoptosis in vitro and in vivo: potential for therapeutics.
Karlberg M; Ekoff M; Huang DC; Mustonen P; Harvima IT; Nilsson G
J Immunol; 2010 Aug; 185(4):2555-62. PubMed ID: 20639495
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.
Tagscherer KE; Fassl A; Campos B; Farhadi M; Kraemer A; Böck BC; Macher-Goeppinger S; Radlwimmer B; Wiestler OD; Herold-Mende C; Roth W
Oncogene; 2008 Nov; 27(52):6646-56. PubMed ID: 18663354
[TBL] [Abstract][Full Text] [Related]
7. ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms.
Kuroda J; Kimura S; Andreeff M; Ashihara E; Kamitsuji Y; Yokota A; Kawata E; Takeuchi M; Tanaka R; Murotani Y; Matsumoto Y; Tanaka H; Strasser A; Taniwaki M; Maekawa T
Br J Haematol; 2008 Jan; 140(2):181-90. PubMed ID: 18028486
[TBL] [Abstract][Full Text] [Related]
8. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
Witham J; Valenti MR; De-Haven-Brandon AK; Vidot S; Eccles SA; Kaye SB; Richardson A
Clin Cancer Res; 2007 Dec; 13(23):7191-8. PubMed ID: 18056200
[TBL] [Abstract][Full Text] [Related]
9. Inner Mitochondrial Membrane Disruption Links Apoptotic and Agonist-Initiated Phosphatidylserine Externalization in Platelets.
Choo HJ; Kholmukhamedov A; Zhou C; Jobe S
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1503-1512. PubMed ID: 28663253
[TBL] [Abstract][Full Text] [Related]
10. The Bcl-2 family protein inhibitor, ABT-737, has substantial antimyeloma activity and shows synergistic effect with dexamethasone and melphalan.
Trudel S; Stewart AK; Li Z; Shu Y; Liang SB; Trieu Y; Reece D; Paterson J; Wang D; Wen XY
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):621-9. PubMed ID: 17255285
[TBL] [Abstract][Full Text] [Related]
11. ACTX-8, a cytotoxic L-amino acid oxidase isolated from Agkistrodon acutus snake venom, induces apoptosis in Hela cervical cancer cells.
Zhang L; Wei LJ
Life Sci; 2007 Mar; 80(13):1189-97. PubMed ID: 17275856
[TBL] [Abstract][Full Text] [Related]
12. Targeting multiple arms of the apoptotic regulatory machinery.
Dai Y; Grant S
Cancer Res; 2007 Apr; 67(7):2908-11. PubMed ID: 17409392
[TBL] [Abstract][Full Text] [Related]
13. P2Y12 protects platelets from apoptosis via PI3k-dependent Bak/Bax inactivation.
Zhang S; Ye J; Zhang Y; Xu X; Liu J; Zhang SH; Kunapuli SP; Ding Z
J Thromb Haemost; 2013 Jan; 11(1):149-60. PubMed ID: 23140172
[TBL] [Abstract][Full Text] [Related]
14. BCL2/BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation.
Vogler M; Hamali HA; Sun XM; Bampton ET; Dinsdale D; Snowden RT; Dyer MJ; Goodall AH; Cohen GM
Blood; 2011 Jun; 117(26):7145-54. PubMed ID: 21562047
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model.
Tomer A; Stahl CP; McClure HM; Anderson DC; Myers LA; Liehl E; Winton EF
Exp Hematol; 1993 Nov; 21(12):1577-82. PubMed ID: 8405239
[TBL] [Abstract][Full Text] [Related]
16. Activation of caspases-9, -3 and -8 in human platelets triggered by BH3-only mimetic ABT-737 and calcium ionophore A23187: caspase-8 is activated via bypass of the death receptors.
Mutlu A; Gyulkhandanyan AV; Freedman J; Leytin V
Br J Haematol; 2012 Dec; 159(5):565-71. PubMed ID: 23025479
[TBL] [Abstract][Full Text] [Related]
17. Actinomycin D decreases Mcl-1 expression and acts synergistically with ABT-737 against small cell lung cancer cell lines.
Xu H; Krystal GW
Clin Cancer Res; 2010 Sep; 16(17):4392-400. PubMed ID: 20732961
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia.
Kuroda J; Kimura S; Strasser A; Andreeff M; O'Reilly LA; Ashihara E; Kamitsuji Y; Yokota A; Kawata E; Takeuchi M; Tanaka R; Tabe Y; Taniwaki M; Maekawa T
Cell Death Differ; 2007 Sep; 14(9):1667-77. PubMed ID: 17510658
[TBL] [Abstract][Full Text] [Related]
19. Programmed anuclear cell death delimits platelet life span.
Mason KD; Carpinelli MR; Fletcher JI; Collinge JE; Hilton AA; Ellis S; Kelly PN; Ekert PG; Metcalf D; Roberts AW; Huang DC; Kile BT
Cell; 2007 Mar; 128(6):1173-86. PubMed ID: 17382885
[TBL] [Abstract][Full Text] [Related]
20. ABT-737, a BH3 mimetic, induces glutathione depletion and oxidative stress.
Howard AN; Bridges KA; Meyn RE; Chandra J
Cancer Chemother Pharmacol; 2009 Dec; 65(1):41-54. PubMed ID: 19404643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
